Novo Nordisk and Sanofi Raising Insulin Prices

Novo Nordisk and Sanofi Raising Insulin Prices

As reported by Alia Paavola for Becker’s Hospital Review, Despite public outrage over the high cost of insulin and drugmaker promises to halt price increases, they continued to climb from 2017 to 2018, according to a GoodRx analysis. Here are seven things to know...

Pin It on Pinterest